US Bill Takes Another Shot At Biosimilar Interchangeability
Draft Legislation Would Classify All Approved Biosimilars As Interchangeable
Draft legislation reintroduced in the US is seeking to remove the need for switching studies to demonstrate biosimilar interchangeability, making all approved biosimilars automatically interchangeable.
